CT-011 MAb in DLBCL Patients Following ASCT
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Arnon Nagler, MD
Chaim Sheba Medical Center
Principal Investigator - Leo I Gordon, MD
Northwestern University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Jaslok Hospital and Research Centre
Mumbai, Maharashtra, India
- Deenanath Mangeshkar Hospital and Research Centre
Pune, Maharashtra, India
- Gujarat Cancer and Research Institute
Ahmedabad, India
- Rajiv Gandhi Cancer Institute and Research Centre
Delhi, India
- Rambam Medical Center
Haifa, Israel
- Hadassah Medical Organization
Jerusalem, Israel
- Chaim Sheba Medical Center
Tel Hashomaer, Ramat Gan, Israel
- Moores Ucsd Cancer Center
La Jolla, California, United States
- Scripps Cancer Center
San Diego, California, United States
- Emory University-Winship Cancer Institute
Atlanta, Georgia, United States
- Northside Hospital
Atlanta, Georgia, United States
- Northwestestern Memorial Hospital
Chicago, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- the University of Chicago
Chicago, Illinois, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Karmanos Cancer Institute
Detroit, Michigan, United States
- University of North Carolina
Chapel Hill, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Case Western Reserve University
Cleveland, Ohio, United States
- Ohio State University
Colombus, Ohio, United States
- Temple University
Philadelphia, Pennsylvania, United States
- the University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
- Cancer Center of the Carolinas
Greenville, South Carolina, United States
- Sarah Cannon Research Institute
Nashville, Tennessee, United States
- Baylor Sammons Cancer Center
Dallas, Texas, United States
- M.D. Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2007
- Primary completion
- 31 Aug 2011
- Completion
- 31 Aug 2011
- Last update posted
- 12 Sept 2014
- Registered enrollment
- 72
- Registry id
- NCT00532259
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.